AWE
GILD icon

Avidian Wealth Enterprises’s Gilead Sciences GILD Stock Holding History

Avidian Wealth Enterprises’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.15M Sell
14,420
-169
-1% -$23.7K 0.06% 208
2026
Q2 		$1.84M Buy
14,589
+727
+5% +$95.8K 0.05% 227
2026
Q1 		$1.93M Buy
13,862
+2,808
+25% +$393K 0.06% 198
2025
Q4 		$1.36M Buy
11,054
+500
+5% +$60.8K 0.05% 182
2025
Q3 		$1.17M Buy
10,554
+510
+5% +$58K 0.04% 198
2025
Q2 		$1.11M Buy
10,044
+367
+4% +$39.1K 0.05% 192
2025
Q1 		$1.08M Buy
9,677
+504
+5% +$52K 0.05% 185
2024
Q4 		$847K Buy
9,173
+561
+7% +$50.5K 0.04% 211
2024
Q3 		$722K Buy
8,612
+310
+4% +$23.7K 0.03% 237
2024
Q2 		$570K Buy
8,302
+1,561
+23% +$104K 0.02% 265
2024
Q1 		$494K Sell
6,741
-1,407
-17% -$108K 0.02% 267
2023
Q4 		$660K Buy
8,148
+259
+3% +$20.2K 0.04% 215
2023
Q3 		$591K Sell
7,889
-204
-3% -$15.7K 0.04% 227
2023
Q2 		$624K Sell
8,093
-1,875
-19% -$150K 0.04% 238
2023
Q1 		$827K Sell
9,968
-8
-0.1% -$663 0.05% 224
2022
Q4 		$856K Buy
9,976
+417
+4% +$33K 0.06% 199
2022
Q3 		$590K Sell
9,559
-1,549
-14% -$97.7K 0.04% 213
2022
Q2 		$687K Buy
11,108
+1,142
+11% +$70.7K 0.05% 219
2022
Q1 		$593K Buy
9,966
+707
+8% +$45.2K 0.04% 270
2021
Q4 		$672K Buy
9,259
+15
+0.2% +$1.03K 0.04% 250
2021
Q3 		$646K Buy
9,244
+631
+7% +$44.3K 0.05% 184
2021
Q2 		$593K Sell
8,613
-137
-2% -$9.15K 0.05% 189
2021
Q1 		$566K Sell
8,750
-701
-7% -$45.2K 0.05% 188
2020
Q4 		$551K Buy
9,451
+425
+5% +$25.6K 0.05% 169
2020
Q3 		$570K Buy
9,026
+3,299
+58% +$229K 0.06% 142
2020
Q2 		$441K Buy
5,727
+1,199
+26% +$91.9K 0.06% 147
2020
Q1 		$339K Buy
4,528
+21
+0.5% +$1.45K 0.05% 135
2019
Q4 		$293K Sell
4,507
-3
-0.1% -$195 0.04% 181
2019
Q3 		$286K Buy
4,510
+304
+7% +$19.9K 0.05% 153
2019
Q2 		$284K Buy
4,206
+1,025
+32% +$67.4K 0.07% 114
2019
Q1 		$207K Buy
+3,181
New +$211K 0.05% 125

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Avidian Wealth Enterprises's GILD Position: Q3 2026 in Review

Avidian Wealth Enterprises reduced its Gilead Sciences (GILD) stake by 1.2% in Q3 2026, selling an estimated $23.7K and leaving 14,420 shares worth $2.15M. The position accounts for 0.06% of the portfolio, ranked #208.

Avidian Wealth Enterprises first reported a position in GILD in Q1 2019 and has held it in 31 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Avidian Wealth Enterprises held 14,420 shares of Gilead Sciences worth $2.15M as of Q3 2026.
  • Avidian Wealth Enterprises sold 169 Gilead Sciences shares in Q3 2026, an estimated $23.7K.
  • Gilead Sciences made up 0.06% of Avidian Wealth Enterprises's portfolio in Q3 2026, its #208 holding.
  • Avidian Wealth Enterprises first reported a position in Gilead Sciences in Q1 2019 and has held it in 31 quarters since.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q3 2026, filed 8 Oct 2026.